Cannabinoids are small organic molecules which bind to specialized receptors on cells in the body and brain. Several different cannabinoids have been identified, many of which are believed to have distinct medicinal effects. While potency testing for THC and CBD content is required for legal classification of marijuana vs. hemp, full cannabinoid profile testing is critical to understanding a specific product’s potential therapeutic effects.
Knowing the cannabinoid profile of medicinal cannabis and marijuana products can aid patients and health care providers in choosing the appropriate product and dose in order to maximize health benefits and minimize unwanted effects. Patients and prescribers across the state of Pennsylvania can confidently achieve accurate dosing when using products analyzed by US Cannalytics.
US Cannalytics utilizes high-performance liquid chromatography (HPLC) coupled with diode array detection (DAD) to quantify the concentrations of 17 active cannabinoids in a wide array of product types.
We analyze all medical cannabis, marijuana, hemp, and CBD samples utilizing ISO-accredited methods for the following cannabinoids: